CATHERINE LIEBIGAKAYCATHERINE LIEBIG AKAY9554AKAY, CATHERINE LIEBIGAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson19770 Kingsland BlvdKaty77094-1031TXAuthorship 1781986Authorship 1815345Authorship 1824447Authorship 1845918Authorship 1846169Authorship 1867082Anesthesiology & PeriOperative MedicineBreast Medical OncologySurgical OncologyMD AndersonHENRY MARKKUERERHENRY MARK KUERER8727KUERER, HENRY MARKProfessorROSA FRANCESHWANGROSA FRANCES HWANG8903HWANG, ROSA FRANCESAssociate ProfessorNAOTO TUENONAOTO T UENO8465UENO, NAOTO TProfessorKELLY KHUNTKELLY K HUNT8555HUNT, KELLY KProfessorELIZABETH ANNMITTENDORFELIZABETH ANN MITTENDORF9277MITTENDORF, ELIZABETH ANNAssociate ProfessorJONATHANWILKSJONATHAN WILKS8707WILKS, JONATHANAssistant Professor0.6532770.0111332110research areas0.8581250.031264840coauthor of26.10974.4699560similar to1117selected publicationsGILDYBABIERAGILDY BABIERA8684BABIERA, GILDYProfessorGEORGE JCHANGGEORGE J CHANG9201CHANG, GEORGE JProfessorAuthorship 2348281Authorship 234850924510381Akay CL, Ueno NT, Chisholm GB, Hortobagyi GN, Woodward WA, Alvarez RH, Bedrosian I, Kuerer HM, Hunt KK, Huo L, Babiera GVCancerPrimary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer. 2014 May 01; 120(9):1319-28.Cancer2014-02-07T00:00:002014Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.25074542Xiang DB, Wei B, Abraham SC, Huo L, Albarracin CT, Zhang H, Babiera G, Caudle AS, Akay CL, Rao P, Zhao YJ, Lu X, Wu YHuman pathologyMolecular cytogenetic characterization of mammary neuroendocrine carcinoma. Hum Pathol. 2014 Sep; 45(9):1951-6.Hum Pathol2014-06-18T00:00:002014Molecular cytogenetic characterization of mammary neuroendocrine carcinoma.Authorship 274313121861223Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EAAnnals of surgical oncologyEvaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol. 2012 Mar; 19(3):901-7.Ann Surg Oncol2011-08-23T00:00:002011Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy.Authorship 289591224711988Takiar V, Akay CL, Stauder MC, Tereffe W, Alvarez RH, Hoffman KE, Perkins GH, Strom EA, Buchholz TA, Ueno NT, Babiera G, Woodward WASpringerPlusPredictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation. Springerplus. 2014; 3:166.Springerplus2014-03-31T00:00:002014Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation.74Professor10Assistant Professor14Associate ProfessorBreast Surgical Oncology17719063Liebig C, Agarwal N, Ayala GE, Verstovsek G, Tuszynski GP, Albo DThe Journal of surgical researchAngiocidin inhibitory peptides decrease tumor burden in a murine colon cancer model. J Surg Res. 2007 Oct; 142(2):320-6.J Surg Res2007-08-23T00:00:002007Angiocidin inhibitory peptides decrease tumor burden in a murine colon cancer model.19268899Wilks JA, Liebig C, Tasleem SH, Haderxhanaj K, Lee L, Farrow B, Awad S, Berger D, Albo DAmerican journal of surgeryRectal cancer patients benefit from implementation of a dedicated colorectal cancer center in a Veterans Affairs Medical Center. Am J Surg. 2009 Jul; 198(1):100-4.Am J Surg2009-03-06T00:00:002009Rectal cancer patients benefit from implementation of a dedicated colorectal cancer center in a Veterans Affairs Medical Center.19484787Liebig C, Ayala G, Wilks JA, Berger DH, Albo DCancerPerineural invasion in cancer: a review of the literature. Cancer. 2009 Aug 01; 115(15):3379-91.Cancer2009-08-01T00:00:002009Perineural invasion in cancer: a review of the literature.21480205Albo D, Akay CL, Marshall CL, Wilks JA, Verstovsek G, Liu H, Agarwal N, Berger DH, Ayala GECancerNeurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes. Cancer. 2011 Nov 01; 117(21):4834-45.Cancer2011-04-08T00:00:002011Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes.19634159Liebig C, Wilks JA, Feig BW, Wang TN, Wilson M, Herdman AV, Albo DCancerThe role of angiocidin in sarcomas. Cancer. 2009 Nov 15; 115(22):5251-62.Cancer2009-11-15T00:00:002009The role of angiocidin in sarcomas.Authorship 858594Authorship 860543Authorship 862048SpringerPlusPredictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation. SpringerPlus. 3:1-9.Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiationBreast DiseasesMargin width should not still enforce a systematic surgical re-excision in the conservative treatment of early breast infiltrative ductal carcinoma. Breast Diseases. 25:245-246.Margin width should not still enforce a systematic surgical re-excision in the conservative treatment of early breast infiltrative ductal carcinomaJournal of Clinical OncologyReply to E.M. Poeschl et al. Journal of Clinical Oncology. 28.Reply to E.M. Poeschl et al19738119Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, Berger DH, Albo DJournal of clinical oncology : official journal of the American Society of Clinical OncologyPerineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol. 2009 Nov 01; 27(31):5131-7.J Clin Oncol2009-09-08T00:00:002009Perineural invasion is an independent predictor of outcome in colorectal cancer.D019700Chemicals & Drugs39550.952357Thrombospondin 1D020360Procedures66449650.385167Neoadjuvant TherapyD021701Procedures22114080.580974Sentinel Lymph Node BiopsyD010446Chemicals & Drugs55412700.63963Peptide FragmentsAuthorship 9138441Authorship 926770928608612Akay CL, Albarracin C, Torstenson T, Bassett R, Mittendorf EA, Yi M, Kuerer HM, Babiera GV, Bedrosian I, Hunt KK, Hwang RFThe breast journalFactors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer. Breast J. 2018 01; 24(1):28-34.Breast J2017-06-13T00:00:002017Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer.28755879DeSnyder SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, Whitman GJ, Ueno NT, Woodward WA, Kuerer HM, Akay CL, Babiera GV, Yang W, Lucci AClinical breast cancerProspective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast?Cancer. Clin Breast Cancer. 2018 02; 18(1):e73-e77.Clin Breast Cancer2017-07-10T00:00:002017Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast?Cancer.D000071036712150.805867Sentinel Lymph NodeAuthorship 1011273733577715Santiago L, Volk RJ, Checka CM, Black D, Lee J, Colen JS, Akay C, Caudle A, Kuerer H, Arribas EMJournal of surgical oncologyAcceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study. J Surg Oncol. 2021 Apr; 123(5):1206-1214.J Surg Oncol2021-02-12T00:00:002021Acceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study.Authorship 1020792534111529Boukovalas S, Liu J, Asaad M, Schaverien MV, Akay C, Garvey PB, Hwang RF, Offodile ACJournal of the American College of SurgeonsRelationship Between Financial Toxicity and Surgical Treatment for Early-Stage Breast Cancer: A Propensity Score-Matched Comparison of Breast-Conserving Therapy and Mastectomy. J Am Coll Surg. 2021 09; 233(3):445-456.e2.J Am Coll Surg2021-06-07T00:00:002021Relationship Between Financial Toxicity and Surgical Treatment for Early-Stage Breast Cancer: A Propensity Score-Matched Comparison of Breast-Conserving Therapy and Mastectomy.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor